Evidence map›Paper›PMID 36223396›Full record

ArticlePloS one2022

Genomic characterization of Francisella tularensis and other diverse Francisella species from complex samples.

David M Wagner, Dawn N Birdsell, Ryelan F McDonough, Roxanne Nottingham, Karisma Kocos, Kimberly Celona, Yasemin Özsürekci, Caroline Öhrman, Linda Karlsson, Kerstin Myrtennäs and 5 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.9field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Draft genomes of three cultured members of a psychrophilicMicrobiology resource announcements · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Strengthening the genomic surveillance ofFrontiers in microbiology · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 4 institutions in 3 countries.

David M WagnerPathogen and Microbiome Institute, Northern Arizona University, Flagstaff, Arizona, United States of America.ORCID 0000-0003-2684-6007
Dawn N BirdsellPathogen and Microbiome Institute, Northern Arizona University, Flagstaff, Arizona, United States of America.
Ryelan F McDonoughPathogen and Microbiome Institute, Northern Arizona University, Flagstaff, Arizona, United States of America.
Roxanne NottinghamPathogen and Microbiome Institute, Northern Arizona University, Flagstaff, Arizona, United States of America.
Karisma KocosPathogen and Microbiome Institute, Northern Arizona University, Flagstaff, Arizona, United States of America.
Kimberly CelonaPathogen and Microbiome Institute, Northern Arizona University, Flagstaff, Arizona, United States of America.
Yasemin ÖzsürekciDepartment of Pediatric Infectious Diseases, Hacettepe University Faculty of Medicine, Ankara, Turkey.
Caroline ÖhrmanCBRN Defence and Security, Swedish Defence Research Agency, Umeå, Sweden.ORCID 0000-0001-8489-757X
Linda KarlssonCBRN Defence and Security, Swedish Defence Research Agency, Umeå, Sweden.
Kerstin MyrtennäsCBRN Defence and Security, Swedish Defence Research Agency, Umeå, Sweden.
Andreas SjödinCBRN Defence and Security, Swedish Defence Research Agency, Umeå, Sweden.
Anders JohanssonDepartment of Clinical Microbiology, Umeå University, Umeå, Sweden.ORCID 0000-0003-0548-5943
Paul S KeimPathogen and Microbiome Institute, Northern Arizona University, Flagstaff, Arizona, United States of America.
Mats ForsmanCBRN Defence and Security, Swedish Defence Research Agency, Umeå, Sweden.
Jason W SahlPathogen and Microbiome Institute, Northern Arizona University, Flagstaff, Arizona, United States of America.
Northern Arizona University · USSwedish Defence Research Agency · SEHacettepe University · TRUmeå University · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Francisella tularensis, the bacterium that causes the zoonosis tularemia, and its genetic near neighbor species, can be difficult or impossible to cultivate from complex samples. Thus, there is a lack of genomic information for these species that has, among other things, limited the development of robust detection assays for F. tularensis that are both specific and sensitive. The objective of this study was to develop and validate approaches to capture, enrich, sequence, and analyze Francisella DNA present in DNA extracts generated from complex samples. RNA capture probes were designed based upon the known pan genome of F. tularensis and other diverse species in the family Francisellaceae. Probes that targeted genomic regions also present in non-Francisellaceae species were excluded, and probes specific to particular Francisella species or phylogenetic clades were identified. The capture-enrichment system was then applied to diverse, complex DNA extracts containing low-level Francisella DNA, including human clinical tularemia samples, environmental samples (i.e., animal tissue and air filters), and whole ticks/tick cell lines, which was followed by sequencing of the enriched samples. Analysis of the resulting data facilitated rigorous and unambiguous confirmation of the detection of F. tularensis or other Francisella species in complex samples, identification of mixtures of different Francisella species in the same sample, analysis of gene content (e.g., known virulence and antimicrobial resistance loci), and high-resolution whole genome-based genotyping. The benefits of this capture-enrichment system include: even very low target DNA can be amplified; it is culture-independent, reducing exposure for research and/or clinical personnel and allowing genomic information to be obtained from samples that do not yield isolates; and the resulting comprehensive data not only provide robust means to confirm the presence of a target species in a sample, but also can provide data useful for source attribution, which is important from a genomic epidemiology perspective.

Indexed as

Anti-Infective AgentsFrancisella tularensisTularemiaAnimalsDNA, BacterialGenomicsHumansPhylogenyRNAAnti-Infective AgentsDNA, BacterialRNA

Identifiers

PMID36223396
PMCPMC9555625
OpenAlexW4304701109

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.